Total Payments
$22,618
2024 Payments
$1,458
Companies
40
Transactions
293
Medicare Patients
9,308
Medicare Billing
$672,398
Payment Breakdown by Category
Other$12,695 (56.1%)
Food & Beverage$6,640 (29.4%)
Travel$3,214 (14.2%)
Education$62.10 (0.3%)
Gifts$6.96 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,133 | 6 | 49.2% |
| Food and Beverage | $6,640 | 262 | 29.4% |
| Travel and Lodging | $3,214 | 19 | 14.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $1,562 | 1 | 6.9% |
| Education | $62.10 | 4 | 0.3% |
| Gift | $6.96 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Baxter Healthcare | $17,179 | 57 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $595.54 | 21 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $448.71 | 21 | $0 (2024) |
| Amgen Inc. | $387.58 | 26 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $362.11 | 12 | $0 (2024) |
| Fresenius USA Marketing, Inc. | $351.42 | 22 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $326.14 | 9 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $311.97 | 9 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $222.41 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $215.51 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,458 | 52 | AstraZeneca Pharmaceuticals LP ($274.31) |
| 2023 | $1,134 | 47 | Mallinckrodt Hospital Products Inc. ($182.27) |
| 2022 | $1,133 | 41 | Alexion Pharmaceuticals, Inc. ($213.35) |
| 2021 | $798.31 | 36 | AstraZeneca Pharmaceuticals LP ($162.72) |
| 2020 | $2,055 | 12 | Baxter Healthcare ($1,937) |
| 2019 | $634.91 | 26 | Mallinckrodt Enterprises LLC ($145.30) |
| 2018 | $12,994 | 52 | BAXTER HEALTHCARE ($12,639) |
| 2017 | $2,410 | 27 | BAXTER HEALTHCARE ($2,121) |
All Payment Transactions
293 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/03/2024 | Baxter Healthcare | Renal - Acute (Device) | Food and Beverage | In-kind items and services | $68.93 | General |
| Category: Renal | ||||||
| 11/20/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/12/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Phosphate binder for ESRD | ||||||
| 11/11/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Nephrology | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Cardio-renal | ||||||
| 10/30/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Hyperkalemia | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: NEPHROLOGY | ||||||
| 09/24/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $126.29 | General |
| Category: Nephrology | ||||||
| 09/23/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: Nephrology | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/12/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: NEPHROLOGY | ||||||
| 09/05/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.28 | General |
| 08/05/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Nephrology | ||||||
| 07/31/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Phosphate binder for ESRD | ||||||
| 07/30/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: NEPHROLOGY | ||||||
| 07/11/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Nephrology | ||||||
| 07/10/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: NEPHROLOGY | ||||||
| 06/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Iron Deficiency Anemia | ||||||
| 06/03/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Inflammation/Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,491 | 3,831 | $471,548 | $137,817 |
| 2022 | 25 | 2,187 | 3,457 | $380,352 | $109,816 |
| 2021 | 26 | 2,214 | 3,537 | $499,854 | $167,934 |
| 2020 | 31 | 2,416 | 12,529 | $828,945 | $256,831 |
Total Patients
9,308
Total Services
23,354
Medicare Billing
$672,398
Procedure Codes
106
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 21 | 144 | $124,560 | $38,117 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 261 | 391 | $119,705 | $26,145 | 21.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 137 | 326 | $55,912 | $19,282 | 34.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 19 | 41 | $29,438 | $9,062 | 30.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 64 | 64 | $30,337 | $8,192 | 27.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 42 | 73 | $17,968 | $6,433 | 35.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 54 | 54 | $21,566 | $5,818 | 27.0% |
| 80069 | Kidney function blood test panel | Office | 2023 | 262 | 432 | $9,936 | $3,664 | 36.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 27 | 31 | $10,033 | $3,049 | 30.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 249 | 393 | $7,860 | $2,955 | 37.6% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 47 | 66 | $6,798 | $2,670 | 39.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 204 | 303 | $6,969 | $2,530 | 36.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 39 | $8,502 | $2,023 | 23.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 261 | 340 | $4,420 | $1,725 | 39.0% |
| 84156 | Total protein level, urine | Office | 2023 | 262 | 342 | $3,420 | $1,228 | 35.9% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 53 | 89 | $3,115 | $1,169 | 37.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 252 | 318 | $2,385 | $988.98 | 41.5% |
| 83550 | Iron binding capacity | Office | 2023 | 52 | 89 | $2,047 | $749.90 | 36.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 40 | 68 | $2,244 | $662.13 | 29.5% |
| 83540 | Iron level | Office | 2023 | 52 | 89 | $1,335 | $560.86 | 42.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 13 | 13 | $975.00 | $377.13 | 38.7% |
| 85018 | Blood count, hemoglobin | Office | 2023 | 53 | 90 | $450.00 | $208.80 | 46.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 20 | 25 | $1,375 | $136.32 | 9.9% |
| 83735 | Magnesium level | Office | 2023 | 11 | 11 | $198.00 | $72.27 | 36.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 247 | 385 | $118,028 | $25,941 | 22.0% |
About Dr. Thomas Wheeler, MD
Dr. Thomas Wheeler, MD is a Nephrology healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1154536506.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Wheeler, MD has received a total of $22,618 in payments from pharmaceutical and medical device companies, with $1,458 received in 2024. These payments were reported across 293 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,133).
As a Medicare-enrolled provider, Wheeler has provided services to 9,308 Medicare beneficiaries, totaling 23,354 services with total Medicare billing of $672,398. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Columbia, SC
- Active Since 05/11/2007
- Last Updated 08/31/2017
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1154536506
Products in Payments
- Renal - Non Product Related (Biological) $15,837
- Renal - Acute (Device) $799.69
- FARXIGA (Drug) $438.22
- JYNARQUE (Drug) $376.50
- TARPEYO (Drug) $362.11
- Velphoro (Drug) $327.54
- ACTHAR (Biological) $295.13
- Renal - CRRT (Device) $290.72
- Veltassa (Drug) $231.98
- LUPKYNIS (Drug) $222.41
- BENLYSTA (Biological) $202.71
- Da Vinci Surgical System (Device) $178.57
- Kerendia (Drug) $156.97
- Auryxia (Drug) $156.16
- Parsabiv (Drug) $154.68
- Parsabiv (Biological) $148.99
- TERLIVAZ (Drug) $142.77
- KRYSTEXXA (Biological) $138.38
- LOKELMA (Drug) $134.52
- Renal - PD (Device) $131.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Columbia
Kunal Chaudhary, Md, MD
Nephrology — Payments: $47,464
Nephrology $47,464
Dr. John Van Stone, M.d, M.D
Nephrology — Payments: $36,779
Nephrology $36,779
Dr. Niall Mclaughlin, Md, MD
Nephrology — Payments: $24,800
Nephrology $24,800
Ramesh Khanna, M.d, M.D
Nephrology — Payments: $14,035
Nephrology $14,035
Dr. Hany Rezk, M.d, M.D
Nephrology — Payments: $11,079
Nephrology $11,079
Dr. Laura Hesemann, M.d, M.D
Nephrology — Payments: $10,678
Nephrology $10,678